Nexafed

Last updated

Nexafed is a formulation of pseudoephedrine developed by Acura Pharmaceuticals used to deter the use of the pseudoephedrine contained in the product for illicit methamphetamine synthesis. [1] Nexafed uses a polymer matrix that forms a thick gel when hydrated, preventing the extraction of pseudoephedrine. [2] Nexafed is the only meth-resistant formulation of pseudoephedrine that shows therapeutic equivalence to Sudafed. [3]

It is sold at various pharmacies in the US, including Fruth Pharmacy [4] [5] and Kroger, particularly in communities where illicit methamphetamine production is an issue.[ citation needed ]

References

  1. ↑ "In fight against crystal meth, a focus on chemistry". cbsnews.com. 2 August 2013. Retrieved 18 July 2016.
  2. ↑ Ricker, Nok-Noi (2016-07-02). "Pharmacies in northern Maine halt sales of certain decongestants to thwart meth labs". Bangor Daily News. Retrieved 2021-11-07.
  3. ↑ Brzeczko, Albert W.; Leech, Ronald; Stark, Jeffrey G. (2013). "The advent of a new pseudoephedrine product to combat methamphetamine abuse". The American Journal of Drug and Alcohol Abuse. 39 (5): 284–290. doi:10.3109/00952990.2013.821476. ISSN   0095-2990. PMC   3793278 . PMID   23968171.
  4. ↑ "Fruth Pharmacy recognized for fighting meth production". drugstorenews.com. Archived from the original on 11 August 2016. Retrieved 18 July 2016.
  5. ↑ Anna Baxter, The Associated Press. "Fruth Pharmacy to Stop Selling Certain Medications to Fight Meth Abuse". wsaz.com. Archived from the original on 10 May 2017. Retrieved 18 July 2016.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.